Background Cardiac cachexia is a condition characterised by unintentional weight loss and muscle wasting in patients with ...

They also are looking into a second-phase study of the drug for possibly treating patients with heart failure and elevated ...

Cardiac cachexia is the weight loss and decrease in appetite that occurs during states of chronically low cardiac output and congestive heart failure. This gives a poor prognosis independent of ...

Ponsegromab is also being tested in a phase 2 study in patients with heart failure and elevated serum GDF-15 concentrations, said the company. Cachexia can also occur with chronic kidney disease ...

And, because cachexia can be a result of many other chronic conditions – including chronic kidney disease, congestive heart failure, HIV and COPD – any viable treatment could become a major ...

Artificial Intelligence in Oncology: Fulfilling Its Promise While Avoiding Its Peril We would like to thank Drs Molfino and Imbimbo 1 for their thoughtful response to our Call to Improve Coding of ...

Cancer cachexia is a devastating wasting syndrome that significantly restricts therapeutic options for cancer patients. The development of treatments has been limited by a lack of in-depth ...